
GC71490
DW71177
Also known as N-[4-[(7-methoxy-1-methyl-[1,2,4]triazolo[4,3-a]quinoxalin-4-yl)amino]butyl]-3-methylbutanamide
DW71177 is a novel [1,2,4]triazolo[4,3-a] quinoxaline-based potent and BD1-Selective BET inhibitor, and can be used for study of acute myeloid leukemia
ChemicalCAS2241311-72-6MW384.48FormulaC20H28N6O2
- CAS number
- 2241311-72-6
- Molecular weight
- 384.48
- Formula
- C20H28N6O2
- Solubility
- DMSO : 50 mg/mL (130·05 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
- InChIKey
- NAPOLFVZKFHOBG-UHFFFAOYSA-N
- Catalogue number
- GC71490
- Brand
- GLPBIO
Computed properties PubChem CID 135276440 · XLogP 3.5 · TPSA 93.4 Ų · H-bond donors 2
- XLogP
- 3.5
- TPSA
- 93.4 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Rotatable bonds
- 9
- Heavy atoms
- 28
SMILES CC1=NN=C2N1C3=C(C=C(C=C3)OC)N=C2NCCCCNC(=O)CC(C)C
Computed descriptors from PubChem (CID 135276440), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il